Journal article
Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections
Antimicrobial agents and chemotherapy, v 61(7)
27 Jun 2017
PMID: 28483952
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Ceftazidime-avibactam is a novel cephalosporin–beta-lactamase inhibitor combination that is active against many carbapenem-resistant Enterobacteriaceae (CRE). We describe a retrospective chart review for 60 patients who received ceftazidime-avibactam for a CRE infection. In-hospital mortality was 32%, 53% of patients had microbiological cure, and 65% had clinical success. In this severely ill population with CRE infections, ceftazidime-avibactam was an appropriate option.
Metrics
Details
- Title
- Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections
- Creators
- Madeline King - Philadelphia UniversityEmily Heil - University of Maryland, BaltimoreSafia Kuriakose - St. Joseph’s University Medical CenterTiffany Bias - Hahnemann University HospitalVanthida Huang - HonorHealthClaudine El-Beyrouty - Thomas Jefferson University HospitalDorothy McCoy - Hackensack University Medical CenterJon Hiles - Indiana University HospitalLynette Richards - St. Joseph’s University Medical CenterJulianne Gardner - Christiana HospitalNicole Harrington - Christiana HospitalKenneth Biason - St. Joseph’s University Medical CenterJason C Gallagher - Temple University
- Publication Details
- Antimicrobial agents and chemotherapy, v 61(7)
- Publisher
- American Society for Microbiology
- Number of pages
- 4
- Resource Type
- Journal article
- Language
- English
- Web of Science ID
- WOS:000406257600042
- Scopus ID
- 2-s2.0-85021996891
- Other Identifier
- 991019330624304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Microbiology
- Pharmacology & Pharmacy